China Carbon Graphite Group, Inc. (CHGI)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Aug 7, 2025	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Market Capitalization	0	2	0	1	2	2
Market Cap Growth	290.02%	283.38%	-22.90%	-69.72%	-5.56%	494.63%
Enterprise Value	-	2	0	0	3	3
Last Close Price	0.00	0.06	0.02	0.02	0.07	0.06
PS Ratio	0.01	3.94	1.23	0.39	1.90	2.47
PB Ratio	0.00	-0.63	-0.18	-0.25	-0.98	-1.20
P/FCF Ratio	0.01	-	174.40	3.93	-	-
P/OCF Ratio	0.01	-	48.90	3.67	-	-
EV/Sales Ratio	-	4.18	1.26	0.34	2.92	3.97
EV/FCF Ratio	-	-	179.46	3.43	-	-
Debt / Equity Ratio	-0.04	-0.05	-0.02	-0.01	-	-
Debt / FCF Ratio	0.39	-	15.24	0.19	-	-
Asset Turnover	0.60	3.08	2.59	8.01	3.34	3.35
Inventory Turnover	0.70	-	12.76	14.90	4.93	7.02
Quick Ratio	0.09	0.01	0.02	0.02	0.01	0.07
Current Ratio	0.23	0.02	0.03	0.02	0.09	0.16
Return on Assets (ROA)	-48.19%	-97.85%	-101.79%	-114.75%	-56.94%	-73.79%
Earnings Yield	-13588.43%	-16.04%	-67.71%	-60.45%	-13.45%	-10.38%
FCF Yield	7635.89%	-5.78%	0.57%	25.42%	-2.29%	-15.11%
Buyback Yield / Dilution	-5.28%	-0.91%	-0.87%	6.01%	14.78%	-0.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.